Cholinergic anti-inflammatory pathway inhibits neointimal hyperplasia by suppressing inflammation and oxidative stress

Autor: Fu-Ming Shen, Yong-Hua Li, Hui Fu, Le-Feng Qu, Pei Wang, Dong-Jie Li, Jie Tong
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
WT
wild type

Vascular smooth muscle
alpha7 Nicotinic Acetylcholine Receptor
GSH
reduced glutathione

Clinical Biochemistry
MPO
myeloperoxidase

Constriction
Pathologic

medicine.disease_cause
Biochemistry
TNF-α
tumor necrosis factor-α

Muscle
Smooth
Vascular

CCL2
chemokines chemokine (C-C motif) ligand 2

Cell Movement
Cholinergic anti-inflammatory pathway
3-NT
3-nitrotyrosine

lcsh:QH301-705.5
Neointimal hyperplasia
Mice
Knockout

lcsh:R5-920
biology
Chemistry
CXCL2
chemokine (CXC motif) ligand 2

CAP
cholinergic anti-inflammatory pathway

NADPH Oxidase 4
Benzamides
NADPH Oxidase 2
NADPH Oxidase 1
cardiovascular system
Tumor necrosis factor alpha
Stents
medicine.symptom
lcsh:Medicine (General)
VSMCs
vascular smooth muscle cells

Research Paper
Neointima
α7 nicotinic acetylcholine receptor
medicine.medical_specialty
IL-1β
interleukin-1β

Inflammation
CNS
central nervous system

α-SMA
α-smooth muscle actin

Superoxide dismutase
03 medical and health sciences
Bridged Bicyclo Compounds
Internal medicine
SOD
superoxide dismutase

medicine
Animals
Humans
Cell Proliferation
MDA
malondialdehyde

KO
knockout

Hyperplasia
Organic Chemistry
α7nAChR
α7 nicotinic acetylcholine receptor

medicine.disease
030104 developmental biology
Endocrinology
Gene Expression Regulation
lcsh:Biology (General)
Oxidative stress
Immunology
biology.protein
Zdroj: Redox Biology, Vol 15, Iss C, Pp 22-33 (2018)
Redox Biology
ISSN: 2213-2317
Popis: Neointimal hyperplasia as a consequence of vascular injury is aggravated by inflammatory reaction and oxidative stress. The α7 nicotinic acetylcholine receptor (α7nAChR) is a orchestrator of cholinergic anti-inflammatory pathway (CAP), which refers to a physiological neuro-immune mechanism that restricts inflammation. Here, we investigated the potential role of CAP in neointimal hyperplasia using α7nAChR knockout (KO) mice. Male α7nAChR-KO mice and their wild-type control mice (WT) were subjected to wire injury in left common carotid artery. At 4 weeks post injury, the injured aortae were isolated for examination. The neointimal hyperplasia after wire injury was significantly aggravated in α7nAChR-KO mice compared with WT mice. The α7nAChR-KO mice had increased collagen contents and vascular smooth muscle cells (VSMCs) amount. Moreover, the inflammation was significantly enhanced in the neointima of α7nAChR-KO mice relative to WT mice, evidenced by the increased expression of tumor necrosis factor-α/interleukin-1β, and macrophage infiltration. Meanwhile, the chemokines chemokine (C-C motif) ligand 2 and chemokine (CXC motif) ligand 2 expression was also augmented in the neointima of α7nAChR-KO mice compared with WT mice. Additionally, the depletion of superoxide dismutase (SOD) and reduced glutathione (GSH), and the upregulation of 3-nitrotyrosine, malondialdehyde and myeloperoxidase were more pronounced in neointima of α7nAChR-KO mice compared with WT mice. Accordingly, the protein expression of NADPH oxidase 1 (Nox1), Nox2 and Nox4, was also higher in neointima of α7nAChR-KO mice compared with WT mice. Finally, pharmacologically activation of CAP with a selective α7nAChR agonist PNU-282987, significantly reduced neointima formation, arterial inflammation and oxidative stress after vascular injury in C57BL/6 mice. In conclusion, our results demonstrate that α7nAChR-mediated CAP is a neuro-physiological mechanism that inhibits neointima formation after vascular injury via suppressing arterial inflammation and oxidative stress. Further, these results imply that targeting α7nAChR may be a promising interventional strategy for in-stent stenosis.
Databáze: OpenAIRE